Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
April 2013 Volume 7 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
April 2013 Volume 7 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Mechanism of chronic dietary iron overload‑induced liver damage in mice

  • Authors:
    • Dan Liu
    • Huan He
    • Dong Yin
    • Ailing Que
    • Lei Tang
    • Zhangping Liao
    • Qiren Huang
    • Ming He
  • View Affiliations / Copyright

    Affiliations: State Key Laboratory of Food Science and Technology, Nanchang University, Nanchang 330047, P.R. China, Department of Pharmacology and Molecular Therapeutics, Nanchang University School of Pharmaceutical Science, Nanchang 330006, P.R. China, Jiangxi Provincial Key Laboratory of Molecular Medicine, Second Affiliated Hospital of Nanchang University, Nanchang 330006, P.R. China
  • Pages: 1173-1179
    |
    Published online on: February 8, 2013
       https://doi.org/10.3892/mmr.2013.1316
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Chronic iron overload may result in hepatic fibrosis and even neoplastic transformation due to a burst of reactive oxygen species (ROS). Mitochondria have been proposed to be important in the production of ROS. The purpose of this study was to investigate the role of the mitochondrial permeability transition pore (mPTP) in the burst of ROS, and to clarify the mechanism whereby ROS induced by iron overload results in hepatic damage. It has been demonstrated that when ferrocene‑induced iron‑overloaded mice were fed the cyclosporin A (CsA), a specific inhibitor of the mPTP, diet (10 mg/kg/day) for 50 days, liver‑to‑body weight ratio, serum levels of alanine transaminase (ALT) and aspartate transaminase (AST), ROS production, mitochondrial swelling, loss of mitochondrial membrane potential (Δψ) and hepatocyte apoptosis decreased. However, the total antioxidant status, including superoxide dismutase (SOD), glutathione peroxidase (GSH‑Px) and catalase activities, increased. The protective effect of CsA on the liver of iron‑overloaded mice may be due to inhibition of the ROS burst and a successive antioxidant effect. To the best of our knowledge, these data provide the first support for the theory that ROS‑induced ROS release (RIRR) may be involved in the burst of ROS in the liver and greatly contribute to the hepatic damage initiated by iron overload.

Introduction

The liver is one of the most iron-rich organs of the body. Approximately 20–30% of the body’s iron is stored in hepatocytes and reticuloendothelial macrophages, thus excessive iron accumulation is clearly observed in the liver. Numerous studies have indicated that dietary iron overload enhances hepatic fibrosis and even induces neoplastic transformation (1,2). These phenomena may be associated with the role of iron in triggering oxidative stress (3). However, the molecular mechanism of iron-induced hepatic damage is poorly understood.

Mitochondria are a potential target of iron-mediated injury, due to the fact that they are intrinsically rich in iron (4). Numerous data have confirmed that mitochondrial dysfunction increases reactive oxygen species (ROS) production, with serious consequences, not only for respiratory function, but also for mitochondrial DNA transcription (5,6). The role of ROS in determining cell fate during exposure to excessive iron is already known; however, the mechanism whereby the burst of ROS is induced by iron overload is not yet understood. The mitochondrial production of ROS may be involved in signal transduction pathways where an initial oxidative stress signal originating at various cell sites is amplified by the mitochondria, the phenomenon of which is termed ROS-induced ROS release (RIRR).

RIRR is generated by circuits requiring mitochondrial membrane channels, including the mitochondrial permeability transition pore (mPTP) (7). mPTPs are multi-protein complexes that are capable of forming large, non-selective pores in the inner mitochondrial membrane (8). They are directly stimulated by environmental factors, such as ROS and injury (9). When the mPTP is continuously open, it causes mitochondrial swelling, which may result in rupture of the outer mitochondrial membrane (10). Generated ROS may subsequently be released into the cytosol and trigger RIRR in the neighboring mitochondria. Thus, mitochondrion-to-mitochondrion RIRR constitutes a positive feedback mechanism for enhanced ROS production that potentially causes hepatic damage.

Due to the fact that iron is a catalyst in the Haber-Weiss reaction and is involved in the initiation of oxygen radical formation (11), we hypothesized that the toxicity of iron overload is associated with mPTP-mediated RIRR. To test this hypothesis, cyclosporin A (CsA) was used to inhibit mPTP opening, in order to explore the underlying mechanisms of hepatic damage induced by iron overload.

Materials and methods

Materials

Ferrocene and CsA were obtained from Sigma (St. Louis, MO, USA). AIN-93G was purchased from Dyets, Inc. (Bethlehem, PA, USA), and 2′,7′-dichlorfluorescein-diacetate (DCFH-DA) and rhodomine 123 were purchased from Molecular Probes (Montluçon, France). William’s medium E (WME) and fetal calf serum (FCS) were obtained from Gibco-BRL (Paisley, Scotland), while collagenase D was purchased from Boehringer Mannheim (Mannheim, Germany). The remaining chemicals were purchased from the local market. Kunming mice were purchased from Tongji Medical School, Huazhong University of Science and Technology (Wuhan, China). The animals were cared for in accordance with the Guide for the Care and Use of Laboratory Animals. The use of animals was reviewed and approved by the Nanchang University Medical College Animal Care Review Committee.

Animal model for dietary iron overload

Thirty-six male Kunming mice, initially weighing 14.7±0.7 g, were used in the present study. Mice were randomly divided into 3 groups designated as control, iron-overloaded and CsA + iron-overloaded. The animal model for dietary iron overload in this study was similar to that described previously (12). Briefly, the iron-overloaded mice were fed for 4 months on a pellet diet (AIN-93G) supplemented with iron in the form of ferrocene, while the CsA + iron-overload group was fed the AIN-93G diet supplemented, not only with iron, but also with CsA (10 mg/kg). Control mice were fed the AIN-93G diet without iron and CsA. Possible differences in dietary consumption among the 3 groups were controlled for; the control animals received an amount of food that was equal to that which the respective treated animals consumed each day. The proportion of iron in the diet was maintained at 0.2% (w/w) for 90 days and then decreased to 0.4% (w/w) for the remaining 30 days. All the groups were kept at 23±2°C under a 12-h dark/light cycle. Animal care in this study conformed to the National Institutes of Health (NIH) Guide for Care and Use of Laboratory Animals (NIH publication 86-23, revised 1986). Following chronic feeding, mice were euthanized by cervical dislocation, and blood was collected by cardiac puncture. The liver was immediately excised, weighed and divided for analysis as described below.

Determination of serum and liver iron concentrations

Serum iron concentration was determined using the assay based on the generation of an iron-ferrozine complex, as described previously by Galleano and Puntarulo (13). Iron concentration in the digested liver sample was measured spectrophotometrically at 535 nm, following reaction with 2 mM bathophenanthroline disulfonic acid (14).

Determination of serum aspartate transaminase (AST) and alanine transaminase (ALT) levels

Serum AST and ALT levels were measured using an autoanalyser (Cobas Integra 400; Holliston, MA, USA) and an ALT/AST reagent kit from Roche Diagnostics (Indianapolis, IN, USA).

Preparation of the mitochondrial fraction

Mitochondria were isolated by conventional differential centrifugation from the liver of mice that had been starved overnight. The livers were homogenized in 250 mM sucrose, 1 mM EGTA and 10 mM HEPES buffer (pH 7.2). The mitochondrial suspension was washed twice in the same medium containing 0.1 mM EGTA, and the final pellet was resuspended in 250 mM sucrose to a final protein concentration of 80–100 mg/ml, measured using the Biuret method, with bovine serum albumin (BSA) as the protein standard.

Mitochondrial swelling

The swelling experiments were conducted according to the procedure performed by Beavis et al(15), at 25°C in a standard medium containing 125 mM sucrose, 10 mM HEPES buffer (pH 7.2), 2.5 mM succinate and 4.0 mM rotenone. The final volume used was 1.0 ml, and the protein concentration was ~0.5 mg/ml. Absorbance changes at 520 nm were monitored in a thermostatically controlled Hitachi U-2000 spectrophotometer.

Hepatocyte preparation

Hepatocytes were isolated by a two-step collagenase perfusion method. Following mechanical disruption of the liver capsule, the liver cells were collected in WME and serially filtered through 30-, 50- and 80-mesh filters in an 85-ml Cellector tissue sieve (Bellco Biotechnology, Vineland, NJ, USA). Typically, 10–25×106 cells were obtained from one mouse liver.

Measurements of intracellular Δψ

The mitochondrial membrane potential (Δψ) was measured by flow cytometry using rhodomine 123, a fluorescent dye that has been demonstrated to selectively accumulate in the mitochondria of living hepatocytes by a mechanism that is dependent on the Δψ (16). The hepatocytes were resuspended in 0.5 ml of 10 μg/ml rhodomine for 15 min at 37°C, and were immediately submitted for flow analysis.

Measurement of intracellular ROS production

To assess the intracellular ROS levels, flow cytometric analyses were performed using the oxidative-sensitive fluorescent probe, DCFH-DA, as previously described (17). Hepatocytes were incubated with 10 μM DCFH-DA for 30 min at 37°C. Formation of 2′,7′-dichlorofluorescein (DCF) was then detected using a FACSCalibur (Becton-Dickinson, Mountain View, CA, USA) equipped with an argon laser (488 nm) in the FL1 channel.

Determination of oxidative stress parameters and lipid peroxidation
MDA

The level of 3,4-methylenedioxyamphetamine (MDA) was determined according to the procedure employed by Okhawa et al(18). Briefly, 0.5 ml supernatant was mixed with 1.5 ml thiobarbituric acid, 1.5 ml acetic acid (pH 3.5), 0.2 ml sodium dodecyl sulfate and 0.5 ml distilled water. Following mixing, the samples and standards were heated at 100°C for 1 h. The absorbance was recorded at 532 nm and compared with that of the MDA standards.

SOD

Superoxide dismutase (SOD) activity was determined according to the method utilised by Beauchamp and Fridovich (19). The reaction mixture consisted of 100 μmol/l xanthine, 100 μmol/l EDTA, 25 μmol/l NBT and 50 mmol/l Na2CO3 (pH 10.2). The reaction was initiated by the addition of xanthine oxidase, and then the absorbance at 560 nm was read every 30 sec for 5 min. SOD activity was assayed spectrophotometrically as the inhibition of the photochemical reduction of NBT at 560 nm.

GSH-Px

Glutathione peroxidase (GSH-Px) activity was measured according to the method employed by Lawrence and Burk (20). The assay reaction comprised 50 mmol/l K2HPO4 buffer, 1 mmol/l EDTA, 1 mmol/l NaN3, 1 mmol/l reduced glutathione, 0.2 mmol/l NADPH, 0.25 mmol/l H2O2 and 1 U/ml glutathione reductase. GSH-Px activity was assayed by monitoring NADPH oxidation at 340 nm, by measuring the absorbance every 15 sec for 5 min. The activity was calculated using a molar extinction coefficient for NADPH of 6.22 mM−1cm−1 at 340 nm.

Catalase

Catalase activity in the liver homogenate was assayed using a modification of the procedure described by Pedraza-Chaverri et al(21). The catalase activity of hepatic homogenates was assayed at 25°C, based on the disappearance of 10 mM H2O2 at 240 nm. The results are expressed as U/mg protein.

TUNEL assay

The terminal deoxynucleotidyl transferase-mediated nick-end labeling (TUNEL) assay was performed to detect hepatocyte apoptosis. The hepatocytes were plated on glass Lab-Tek Chamber slides (Sigma) and washed with PBS, then fixed in 1% paraformaldehyde for 10 min. These were then postfixed in pre-cooled ethanol-acetic acid (2:1) for a further 5 min at −20°C. Following washing with PBS, the cells were incubated with a TUNEL reaction buffer at 37°C for 1 h in a humidified chamber. As a positive control, cells were treated with DNase I (1.0 mg/ml, Sigma) for 10 min, to introduce nicks into the genomic DNA. The percentage of cardiomyocytes with DNA nick-end labeling was determined by counting the number of cells exhibiting brown nuclei among 1,000 cells in duplicate plates.

Statistical analysis

Values were expressed as the mean ± standard deviation from ≥12 independent experiments. Each treatment was performed in triplicate culture wells. The differences in the means between each group were tested by one-way ANOVA followed by the Student-Newman-Keuls test (comparison between multiple groups). P<0.05 was considered to indicate a statistically significant difference.

Results

Effects of CsA administration on serum and hepatic iron concentrations in iron-overloaded mice

As expected, the serum and hepatic iron concentrations were significantly increased in all treated animals. When mice were supplemented with CsA, the serum and hepatic iron concentrations were not significantly different compared with those of the iron-overloaded group. This observation suggests that the severe iron loading caused by a continuous iron-supplemented diet was not alleviated by CsA aministration (Fig. 1).

Figure 1

Effects of cyclosporin A (CsA) on serum and hepatic iron concentrations in iron-overloaded mice. Mice were randomly divided into 3 groups and treated as described in Materials and methods. (A) Non-heme iron content in the serum of mice in the different treatment groups. The blood was collected by cardiac puncture. Serum iron concentration was determined using the assay based on the generation of an iron-ferrozine complex. (B) Liver iron content in the liver of mice in the different treatment groups. The liver was immediately removed and weighed, then digested by nitric acid and perchloric acid mixed at a ratio of 4:1. Iron content was assayed. Values are the mean ± standard deviation (n=12). aP<0.01 vs. control; cP>0.05 vs. iron-overloaded group.

Effects of CsA administration on liver-to-body weight ratio (%) and serum levels of transaminases in iron-overloaded mice

There were no obvious health abnormalities in any of the groups, but the liver-to-body weight ratio was significantly increased in all the treated animals. Compared with the iron-overloaded group, CsA showed significant protection against iron overload in the CsA + iron-overloaded group (P<0.01).

Serum levels of transaminases (ALT and AST) were used as indicators to evaluate the involvement of CsA in the structural damage to the liver. In this experiment, the enzyme assays of serum transaminases demonstrated that the iron overload significantly raised the levels of ALT and AST to 227.1 and 381.3 U/l, respectively (P<0.01 for both). CsA was capable of effectively inhibiting the enzyme activity. The levels of ALT and AST were reduced to 125.5 and 220.1 U/l, respectively (P<0.01 for both) when CsA was administered. This result revealed that the negative effect of iron overload in mice may be alleviated by CsA administration (Fig. 2).

Figure 2

Effects of cyclosporin A (CsA) on the liver-to-body weight ratio (%) and serum levels of transaminases of iron-overloaded mice. Mice were randomly divided into 3 groups and treated as described in Materials and methods. (A and B) Alanine transaminase (ALT) and aspartate transaminase (AST) activities in the serum of mice in the different treatment groups. The blood was collected by cardiac puncture. Serum AST and ALT levels were measured as described in Materials and methods. (C) Liver-to-body weight ratio of mice in the different treatment groups. The liver was immediately removed and weighed and the liver-to-body weight ratio was calculated. Values are the mean ± standard deviation (n=12). aP<0.01 vs. control; bP<0.01 vs. iron-overloaded group; dP<0.05 vs. control and iron-overloaded groups.

Effects of CsA administration on hepatocyte apoptosis in iron-overloaded mice

In the control group, a limited number of TUNEL-positive hepatocytes were detected. By contrast, numerous hepatocytes in the iron-overloaded group presented as positive for TUNEL, and this number was significantly greater than that of the control group (P<0.01). The number of TUNEL-positive cells was significantly reduced (10.4±2.1%) compared with the iron-overloaded group when CsA was administered (P<0.01) (Fig. 3).

Figure 3

Effects of cyclosporin A (CsA) on liver apoptosis in iron-overloaded mice. Following 4 months of feeding, mice were euthanized by cervical dislocation. Livers were immediately removed and fixed by perfusion with 10% buffered formalin, and 5-μm paraffin-embedded sections were obtained. Subsequently, the sections were subjected to terminal deoxynucleotidyl transferase-mediated nick-end labeling (TUNEL) assay. (A-C) Detection of apoptotic hepatocytes by TUNEL in the different groups: (A) control, (B) iron-overloaded and (C) CsA + iron-overloaded. Representative photomicrographs show TUNEL-positive apoptotic hepatocytes. Original magnification, ×200. (D) Quantitative analysis of apoptotic hepatocytes expressed as the percentage of TUNEL-positive nuclei in hepatocytes. Values are the mean ± standard deviation (n=12). aP<0.01 vs. control; bP<0.01 vs. iron-overloaded group.

Effects of CsA administration on the oxidative parameters of iron-overloaded mice

The effects of CsA on the oxidative stress of iron-overloaded mice (n=12) were estimated by determining the activities of MDA, SOD, GSH-Px and catalase in the liver tissue. The MDA level is a key marker of endogenous lipid peroxidation. In the iron-overloaded group, the MDA level increased significantly in the liver compared with the control group (P<0.01). By contrast, the MDA level in the CsA-treated group decreased significantly compared with the ferrocene-treated group (P<0.01). This revealed that CsA was able to successfully block lipid peroxidation. SOD, GSH-Px and catalase are intracellular antioxidant enzymes that protect against oxidative processes. As shown in Table I, iron overload induced severe oxidative damage and the SOD, GSH-Px and catalase levels decreased markedly, while CsA effectively normalized the enzyme activities.

Table I

Effects of CsA on oxidative stress parameters in iron-overloaded mice.

Table I

Effects of CsA on oxidative stress parameters in iron-overloaded mice.

IndexControl Iron-overloadedCsA + iron-overloaded
SOD activity (U/mg protein)382.2±15.5120.1±5.0a302.6±13.0b
GSH-Px activity (mU/mg protein)248.4±8.9..108.6±4.0a160.3±6.2a,b
Catalase activity (U/mg protein)316.2±14.5186.3±6.5a271.6±8.7b..
MDA content (pmol/mg protein)130.4±4.4..518.5±21.1a281.2±10.3a,b

{ label (or @symbol) needed for fn[@id='tfn1-mmr-07-04-1173'] } CsA, cyclosporin A; SOD, superoxide dismutase; GSH-Px, glutathione peroxidase; MDA, 3,4-methylenedioxyamphetamine. Data are expressed as the mean ± standard deviation (n=12).

a P<0.01 vs. control;

b P<0.01 vs. iron-overloaded group.

Effects of CsA administration on mitochondrial swelling in iron-overloaded mice

Iron-induced damage to the inner mitochondrial membrane may be assessed by the classic swelling techniques, which monitor the net influx of the osmotic support that is associated with a non-specific increase in membrane permeability. It was demonstrated that iron-dextran induced mitochondrial swelling, as revealed by the large decrease in the absorbance of the mitochondrial suspension at 520 nm. However, CsA inhibited the swelling process (P<0.01) (Fig. 4).

Figure 4

Effects of cyclosporin A (CsA) on the mitochondrial swelling of iron-overloaded mice. Mitochondria were isolated by conventional differential centrifugation from the liver of mice. The swelling experiments were conducted as decribed in Materials and methods. (A) Effect of CsA and iron overload on Ca2+-induced mitochondrial swelling. During the onset of mitochondrial swelling, 150 μM Ca2+ was added to initiate the reaction. (B) Quantitative analysis of mitochondrial swelling. Values are the mean ± standard deviation (n=12). aP<0.01 vs. control; bP<0.01 vs. iron-overloaded group.

Effects of CsA administration on Δψ of iron-overloaded mice

The Δψ was determined by the Δψ-sensitive fluorescent probe, rhodimine 123. The findings revealed that iron overload induced Δψ depolarization and CsA prevented Δψ dissipation (Fig. 5).

Figure 5

Effects of cyclosporin A (CsA) on the mitochondrial membrane potential (Δψ) of iron-overloaded mice. Livers were removed and hepatocytes were isolated by a two-step collagenase perfusion method. (A) Effects of CsA or iron overload on the Δψ. Hepatocytes were immediately collected, resuspended in PBS, stained with Rho 123 for 15 min and subjected to flow cytometry. (B) Quantitative analysis of Δψ. Values are the mean ± standard deviation (n=12). aP<0.01 vs. control; bP<0.01 vs. iron-overloaded group.

Effects of CsA administration on ROS production in iron-overloaded mice

By flow cytometry, using the DCFH-DA fluorescent probe, it was demonstrated that iron-dextran induced ROS production. As expected, iron overload induced a ROS burst, while ROS overproduction was prevented when CsA was added simultaneously to iron (P<0.01) (Fig. 6).

Figure 6

Effects of cyclosporin A (CsA) on reactive oxygen species (ROS) production in iron-overloaded mice. (A) Effects of CsA or iron overload on intracellular ROS levels in hepatocytes. The figure shows the overlay of three representative fluorescence flow cytometric analyses performed in hepatocytes. (B) Quantitative analysis of ROS production. Values are the mean ± standard deviation (n=12). aP<0.01 vs. control; bP<0.01 vs. iron-overloaded group.

Discussion

Iron is an essential micronutrient. The capacity of readily exchanging electrons under aerobic conditions causes iron to be essential for fundamental cell functions, such as DNA synthesis, transport of oxygen and electrons, and cell respiration (22). However, as humans have no means to control their iron excretion, excess iron consumed in the diet accumulates in parenchymal organs and threatens cell viability (23). In the current study, in mice fed a diet supplemented with ferrocene, severe iron overload occurred and cell damage arose mainly in the liver (the body’s main storage site for iron). In the present study, a specific inhibitor of mPTP, CsA, was used (24). Notably, CsA was unable to reduce iron accumulation in the liver, but it was able to protect the liver from iron overload.

The mPTP is a voltage-dependent, high-conductance channel located in the inner mitochondrial membrane, which has been suggested to be formed by the interaction of several proteins that connect the mitochondrial matrix to the cytosolic space (25). It has been proposed that the mPTP is able to open in two modes: low and high conductance (26). When mPTPs are opened in the long-lasting high-conductance mode, necrosis and apoptosis are initiated (27). In the physiological setting, ROS is the most important inducer of mPTP opening (28).

The chemical structure of iron and its ability to drive one-electron reactions causes iron to be key for the production and metabolism of ROS in biological systems. A previous study clearly demonstrated that these pathological events are induced by iron-generated ROS (29). As demonstrated in the present study, such an iron burden initiates significant oxidative stress. We found that the production of ROS was greater in the iron-overloaded group compared with the control group. ROS are capable of causing oxidative damage to macromolecules, leading to lipid peroxidation, oxidation of amino acid side chains (particularly cysteine), formation of protein-protein cross-links and oxidation of polypeptide backbones, resulting in protein fragmentation, hepatic cell apoptosis and even necrosis (30).

Iron, as a transition metal catalyst, is essential for the initiation step in the generation of ROS. Subsequently, excess ROS are the major cause of liver damage. Nevertheless, the mechanism of the burst of ROS induced by iron overload has not yet been clarified. Recent data have confirmed that mitochondria are also capable of producing a significant ROS release when the Δψ is null following mPTP opening (31,32). Additionally, ROS are the most important inducer of mPTP opening (33). These transitions have been described and occur via mechanisms involved in the process of RIRR (31,32). Although the phenomenon of RIRR initiated by ischemic reperfusion injury has been confirmed in cardiomyocytes (34), RIRR initiated by iron overload has not yet been demonstrated in hepatocytes. We suggest that under conditions that lead to RIRR, such as exposure to iron overload, the increase in ROS reaches a threshold level triggering mPTP opening, which in turn leads to the simultaneous collapse of Δψ and a transient increase in ROS generation by the electron transfer chain (35). The release of this ROS burst into the cytosol may potentially function as a second messenger to activate RIRR in the neighboring mitochondria. Thus, mitochondrion-to-mitochondrion RIRR constitutes a positive feedback mechanism for enhanced ROS production, potentially leading to significant mitochondrial and cell injury. RIRR is generated by circuits requiring mitochondrial membrane channels, including the mPTP. Therefore, the mPTP is important in RIRR. Our present results have demonstrated that the large-amplitude ROS burst initiated by iron overload was prevented by the administration of CsA. Moreover, depolarization and apoptosis were prevented, while inhibition of the ROS burst in mice was estimated by determining the activities of MDA, SOD, GSH-Px, catalase, ALT and AST in serum and tissues. CsA not only protected the liver from damage by efficiently inhibiting MDA formation, and by reducing AST and ALT, but it also enhanced the activities of the antioxidant enzyme system of the host, including those of SOD, GSH-Px and catalase.

Similar to the propagation of mitochondrial depolarization and ROS production demonstrated in isolated cardiomyocytes by Zorov et al(34), it has been observed that mPTP-mediated RIRR also exists in liver subjected to iron overload. Iron overload initiates the generation of ROS, and ROS induce mPTP opening. Extensive matrix swelling with long-lasting mPTP opening may lead to the unfolding of cristae, causing the outer membrane to rupture, irreversibly damaging the mitochondria, and consequently, ROS are released from the mitochondrial matrix into the cytosol. Thus, ROS may potentially function as a second messenger to activate RIRR in the neighboring mitochondria, and the liver overloaded with iron becomes damaged.

In conclusion, our results strongly support the hypothesis that RIRR mediated by mPTP may generate a large number of ROS, and provide a possible mechanism by which excess dietary iron uptake results in liver damage in mice.

Acknowledgements

This study was supported by grants from the Natural Scientific Foundations of China (grant nos. 30760075, 30860271 and 81100104).

References

1 

Nahon P, Ganne-Carrié N, Trinchet JC and Beaugrand M: Hepatic iron overload and risk of hepatocellular carcinoma in cirrhosis. Gastroenterol Clin Biol. 34:1–7. 2010. View Article : Google Scholar : PubMed/NCBI

2 

Allen KJ, Gurrin LC, Constantine CC, et al: Iron-overload-related disease in HFE hereditary hemochromatosis. N Engl J Med. 358:221–230. 2008. View Article : Google Scholar : PubMed/NCBI

3 

Asare GA, Kew MC, Mossanda KS, Paterson AC, Siziba K and Kahler-Venter CP: Effects of exogenous antioxidants on dietary iron overload. J Clin Biochem Nutr. 44:85–94. 2009. View Article : Google Scholar : PubMed/NCBI

4 

Pardo Andreu GL, Inada NM, Vercesi AE and Curti C: Uncoupling and oxidative stress in liver mitochondria isolated from rats with acute iron overload. Arch Toxicol. 83:47–53. 2009.PubMed/NCBI

5 

Starkov AA: The role of mitochondria in reactive oxygen species metabolism and signaling. Ann NY Acad Sci. 1147:37–52. 2008. View Article : Google Scholar : PubMed/NCBI

6 

Murphy MP: How mitochondria produce reactive oxygen species. Biochem J. 417:1–13. 2009. View Article : Google Scholar : PubMed/NCBI

7 

Brady NR, Elmore SP, van Beek JJ, Krab K, Courtoy PJ, Hue L and Westerhoff HV: Coordinated behavior of mitochondria in both space and time: a reactive oxygen species-activated wave of mitochondrial depolarization. Biophys J. 87:2022–2034. 2004. View Article : Google Scholar

8 

Gateau-Roesch O, Argaud L and Ovize M: Mitochondrial permeability transition pore and postconditioning. Cardiovasc Res. 70:264–273. 2006. View Article : Google Scholar : PubMed/NCBI

9 

Saotome M, Katoh H, Yaguchi Y, Tanaka T, Urushida T, Satoh H and Hayashi H: Transient opening of mitochondrial permeability transition pore by reactive oxygen species protects myocardium from ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol. 296:H1125–H1132. 2009. View Article : Google Scholar

10 

Halestrap AP: Calcium, mitochondria and reperfusion injury: a pore way to die. Biochem Soc Trans. 34:232–237. 2006. View Article : Google Scholar : PubMed/NCBI

11 

Galaris D, Skiada V and Barbouti A: Redox signaling and cancer: the role of ‘labile’ iron. Cancer Lett. 266:21–29. 2008.

12 

Tjalkens RB, Valerio LG Jr, Awasthi YC and Petersen DR: Association of glutathione S-transferase isozyme-specific induction and lipid peroxidation in two inbred strains of mice subjected to chronic dietary iron overload. Toxicol Appl Pharmacol. 151:174–181. 1998. View Article : Google Scholar : PubMed/NCBI

13 

Galleano M and Puntarulo S: Hepatic chemiluminescence and lipid peroxidation in mild iron overload. Toxicology. 76:27–38. 1992. View Article : Google Scholar : PubMed/NCBI

14 

Brumby PE and Massey V: Determination of nonheme iron, total iron, and copper. Methods Enzymol. 10:463–474. 1967. View Article : Google Scholar

15 

Beavis AD, Brannan RD and Garlid KD: Swelling and contraction of the mitochondrial matrix. I A structural interpretation of the relationship between light scattering and matrix volume. J Biol Chem. 260:13424–13433. 1985.PubMed/NCBI

16 

Emaus RK, Grunwald R and Lemasters JJ: Rhodamine 123 as a probe of transmembrane potential in isolated rat-liver mitochondria: spectral and metabolic properties. Biochim Biophys Acta. 850:436–448. 1986. View Article : Google Scholar : PubMed/NCBI

17 

Desmots F, Rissel M, Pigeon C, Loyer P, Loréal O and Guillouzo A: Differential effects of iron overload on GST isoform expression in mouse liver and kidney and correlation between GSTA4 induction and overproduction of free radicals. Free Radic Biol Med. 32:93–101. 2002. View Article : Google Scholar : PubMed/NCBI

18 

Okhawa H, Ohishi N and Yagi K: Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 95:351–358. 1979. View Article : Google Scholar : PubMed/NCBI

19 

Beauchamp C and Fridovich I: Superoxide dismutase: improved assays and an assay applicable to acrylamide gels. Anal Biochem. 44:276–287. 1971. View Article : Google Scholar : PubMed/NCBI

20 

Lawrence RA and Burk RF: Glutathione peroxidase activity in selenium-deficient rat liver. Biochem Biophys Res Commun. 71:952–958. 1976. View Article : Google Scholar : PubMed/NCBI

21 

Pedraza-Chaverri J, Granados-Silvestre MD, Medina-Campos ON and Hernández-Pando R: Effect of the in vivo catalase inhibition on aminonucleoside nephrosis. Free Radic Biol Med. 27:245–253. 1999. View Article : Google Scholar : PubMed/NCBI

22 

Ramm GA and Ruddell RG: Iron homeostasis, hepatocellular injury, and fibrogenesis in hemochromatosis: the role of inflammation in a noninflammatory liver disease. Semin Liver Dis. 30:271–287. 2010. View Article : Google Scholar : PubMed/NCBI

23 

Chen J and Chloupková M: Abnormal iron uptake and liver cancer. Cancer Biol Ther. 8:1699–1708. 2009. View Article : Google Scholar : PubMed/NCBI

24 

Xie JR and Yu LN: Cardioprotective effects of cyclosporine A in an in vivo model of myocardial ischemia and reperfusion. Acta Anaesthesiol Scand. 51:909–913. 2007. View Article : Google Scholar : PubMed/NCBI

25 

Halestrap AP, McStay GP and Clarke SJ: The permeability transition pore complex: another view. Biochimie. 84:153–166. 2002. View Article : Google Scholar : PubMed/NCBI

26 

Novgorodov SA and Gudz TI: Permeability transition pore of the inner mitochondrial membrane can operate in two open states with different selectivities. J Bioenerg Biomembr. 28:139–146. 1996. View Article : Google Scholar : PubMed/NCBI

27 

Joza N, Susin SA, Daugas E, et al: Essential role of the mitochondrial apoptosis-inducing factor in programmed cell death. Nature. 410:549–554. 2001. View Article : Google Scholar : PubMed/NCBI

28 

Halestrap AP: The mitochondrial permeability transition - a‘pore way for the heart to die. J Clin Basic Cardiol. 5:29–41. 2002.

29 

Galaris D and Pantopoulos K: Oxidative stress and iron homeostasis: mechanistic and health aspects. Crit Rev Clin Lab Sci. 45:1–23. 2008. View Article : Google Scholar : PubMed/NCBI

30 

Van HB, Woshner V and Santos JH: Role of mitochondrial DNA in toxic responses to oxidative stress. DNA Repair (Amst). 5:145–152. 2006. View Article : Google Scholar : PubMed/NCBI

31 

Zorov DB, Juhaszova M and Sollott SJ: Mitochondrial ROS-induced ROS release: an update and review. Biochim Biophys Acta. 1757:509–517. 2006. View Article : Google Scholar : PubMed/NCBI

32 

Brady NR, Hamacher-Brady A, Westerhoff HV and Gottlieb RA: A wave of reactive oxygen species (ROS)-induced ROS release in a sea of excitable mitochondria. Antioxid Redox Signal. 8:1651–1665. 2006. View Article : Google Scholar : PubMed/NCBI

33 

Serviddio G, Bellanti F, Sastre J, Vendemiale G and Altomare E: Targeting mitochondria: a new promising approach for the treatment of liver diseases. Curr Med Chem. 17:2325–2337. 2010. View Article : Google Scholar : PubMed/NCBI

34 

Zorov DB, Filburn CR, Klotz LO, Zweier JL and Sollott SJ: Reactive oxygen species (ROS)-induced ROS release: a new phenomenon accompanying induction of the mitochondrial permeability transition in cardiac myocytes. J Exp Med. 192:1001–1014. 2000. View Article : Google Scholar

35 

Batandier C, Leverve X and Fontaine E: Opening of the mitochondrial permeability transition pore induces reactive oxygen species production at the level of the respiratory chain complex I. J Biol Chem. 279:17197–17204. 2004. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Liu D, He H, Yin D, Que A, Tang L, Liao Z, Huang Q and He M: Mechanism of chronic dietary iron overload‑induced liver damage in mice. Mol Med Rep 7: 1173-1179, 2013.
APA
Liu, D., He, H., Yin, D., Que, A., Tang, L., Liao, Z. ... He, M. (2013). Mechanism of chronic dietary iron overload‑induced liver damage in mice. Molecular Medicine Reports, 7, 1173-1179. https://doi.org/10.3892/mmr.2013.1316
MLA
Liu, D., He, H., Yin, D., Que, A., Tang, L., Liao, Z., Huang, Q., He, M."Mechanism of chronic dietary iron overload‑induced liver damage in mice". Molecular Medicine Reports 7.4 (2013): 1173-1179.
Chicago
Liu, D., He, H., Yin, D., Que, A., Tang, L., Liao, Z., Huang, Q., He, M."Mechanism of chronic dietary iron overload‑induced liver damage in mice". Molecular Medicine Reports 7, no. 4 (2013): 1173-1179. https://doi.org/10.3892/mmr.2013.1316
Copy and paste a formatted citation
x
Spandidos Publications style
Liu D, He H, Yin D, Que A, Tang L, Liao Z, Huang Q and He M: Mechanism of chronic dietary iron overload‑induced liver damage in mice. Mol Med Rep 7: 1173-1179, 2013.
APA
Liu, D., He, H., Yin, D., Que, A., Tang, L., Liao, Z. ... He, M. (2013). Mechanism of chronic dietary iron overload‑induced liver damage in mice. Molecular Medicine Reports, 7, 1173-1179. https://doi.org/10.3892/mmr.2013.1316
MLA
Liu, D., He, H., Yin, D., Que, A., Tang, L., Liao, Z., Huang, Q., He, M."Mechanism of chronic dietary iron overload‑induced liver damage in mice". Molecular Medicine Reports 7.4 (2013): 1173-1179.
Chicago
Liu, D., He, H., Yin, D., Que, A., Tang, L., Liao, Z., Huang, Q., He, M."Mechanism of chronic dietary iron overload‑induced liver damage in mice". Molecular Medicine Reports 7, no. 4 (2013): 1173-1179. https://doi.org/10.3892/mmr.2013.1316
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team